litlas
Log inCreate account

Debu Tripathy

Active 1996–2026

148
Papers
21,853
Citations
67
h-index
138
i10-index

Citations

Citations per year for Debu Tripathy1964: 1 citations1981: 1 citations1993: 1 citations1996: 1 citations1997: 18 citations1998: 18 citations1999: 59 citations2000: 109 citations2001: 163 citations2002: 155 citations2003: 156 citations2004: 158 citations2005: 150 citations2006: 143 citations2007: 147 citations2008: 132 citations2009: 179 citations2010: 126 citations2011: 93 citations2012: 106 citations2013: 102 citations2014: 90 citations2015: 94 citations2016: 88 citations2017: 91 citations2018: 132 citations2019: 480 citations2020: 703 citations2021: 740 citations2022: 640 citations2023: 620 citations2024: 904 citations2025: 549 citations2026: 22 citations1965–1980: no citations, so these years are not shown1982–1992: no citations, so these years are not shown1994–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,692 citing papers, 28.4% of this breakdownChina: 1,004 citing papers, 10.6% of this breakdownItaly: 548 citing papers, 5.8% of this breakdownUnited Kingdom: 497 citing papers, 5.2% of this breakdownGermany: 459 citing papers, 4.8% of this breakdownCanada: 363 citing papers, 3.8% of this breakdownSpain: 337 citing papers, 3.6% of this breakdownFrance: 334 citing papers, 3.5% of this breakdownAustralia: 253 citing papers, 2.7% of this breakdownSwitzerland: 207 citing papers, 2.2% of this breakdownJapan: 203 citing papers, 2.1% of this breakdownNetherlands: 189 citing papers, 2% of this breakdown
0%28.4%Other 25.3%

Institutions

Fields

  • Medicine66.6%
  • Biochemistry, Genetics and Molecular Biology25.4%
  • Immunology and Microbiology1.8%
  • Materials Science1.4%
  • Computer Science1.2%
  • Engineering0.8%
  • Other2.8%

Topics

  • HER2/EGFR in Cancer Research9.6%
  • Advanced Breast Cancer Therapies6.4%
  • Breast Cancer Treatment Studies5.5%
  • Monoclonal and Polyclonal Antibodies Research4.4%
  • Cancer Genomics and Diagnostics3.1%
  • Cancer-related Molecular Pathways2.9%
  • Other68.1%

Coauthors

All papers

Open in search
  1. Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival

    Authors: Mark Jesus M. Magbanua, Lamorna Brown Swigart, H.-T. Wu, Gillian L. Hirst, Christina Yau, Denise M. Wolf, Aung Soe Tin, Raheleh Salari, Svetlana Shchegrova, H. Pawar, Amy L. Delson, Angela DeMichele, M.C. Liu, A. Jo Chien, Debu Tripathy, Smita Asare, C-HJ Lin, Paul R. Billings, Alexey Aleshin, Himanshu Sethi, Maggie C. Louie, Bernhard Zimmermann, Laura J. Esserman, Laura van ‘t Veer - Annals of Oncology 2020 cited by 438

  2. Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial

    Authors: Debu Tripathy, Seock‐Ah Im, Marco Colleoni, Fábio Franke, Aditya Bardia, Nadia Harbeck, Sara A. Hurvitz, Louis W.C. Chow, Joohyuk Sohn, Keun Seok Lee, Saúl Campos-Gómez, Rafael Villanueva-Vázquez, Kyung Hae Jung, Govind Babu, Paul Wheatley‐Price, Michelino De Laurentiis, Young‐Hyuck Im, Sherko Küemmel, Nagi S. El-Saghir, Mei-Ching Liu, Gary P. Carlson, Gareth Hughes, Iván Díaz-Padilla, Caroline Germa, Samit Hirawat, Yen‐Shen Lu - The Lancet Oncology 2018 cited by 1,011

  3. Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer

    Authors: Seock‐Ah Im, Yen‐Shen Lu, Aditya Bardia, Nadia Harbeck, Marco Colleoni, Fábio Franke, Louis W.C. Chow, Joohyuk Sohn, Keun-Seok Lee, Saúl Campos-Gómez, Rafael Villanueva-Vázquez, Kyung-Hae Jung, Arunava Chakravartty, Gareth Hughes, Ioannis Gounaris, Karen Rodriguez-Lorenc, Tetiana Taran, Sara A. Hurvitz, Debu Tripathy - New England Journal of Medicine 2019 cited by 1,021

  4. Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy

    Authors: Mark Jesus M. Magbanua, Lamorna Brown Swigart, Ziad Ahmed, Rosalyn W. Sayaman, Derrick Renner, Ekaterina Kalashnikova, Gillian L. Hirst, Christina Yau, Denise M. Wolf, Wen Li, Amy L. Delson, Smita Asare, Minetta C. Liu, Kathy S. Albain, A. Jo Chien, Andres Forero‐Torres, Claudine Isaacs, Rita Nanda, Debu Tripathy, Angel Rodriguez, Himanshu Sethi, Alexey Aleshin, Matthew Rabinowitz, Jane Perlmutter, W. Fraser Symmans, Douglas Yee, Nola M. Hylton, Laura J. Esserman, Angela DeMichele, Hope S. Rugo, Laura van ‘t Veer - Cancer Cell 2023 cited by 171

  5. Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2− Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial

    Authors: Yen-Shen Lu, Seock-Ah Im, Marco Colleoni, Fabio Franke, Aditya Bardia, Fatima Cardoso, Nadia Harbeck, Sara Hurvitz, Louis Chow, Joohyuk Sohn, Keun Seok Lee, Saul Campos-Gomez, Rafael Villanueva Vazquez, Kyung Hae Jung, K. Govind Babu, Paul Wheatley-Price, Michelino De Laurentiis, Young-Hyuck Im, Sherko Kuemmel, Nagi El-Saghir, Ruth O'Regan, Claudia Gasch, Nadia Solovieff, Craig Wang, Yongyu Wang, Arunava Chakravartty, Yan Ji, Debu Tripathy - Clinical Cancer Research 2021 cited by 263

  6. Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment

    Authors: Heather Greenlee, Melissa J. DuPont‐Reyes, Lynda G. Balneaves, Linda E. Carlson, Misha Cohen, Gary Deng, Jillian A. Johnson, Matthew P. Mumber, Dugald Seely, Suzanna M. Zick, Lindsay Boyce, Debu Tripathy - CA A Cancer Journal for Clinicians 2017 cited by 768

  7. Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer: A Randomized Controlled Trial

    Authors: Christina M. Dieli‐Conwright, Kerry S. Courneya, Wendy Demark‐Wahnefried, Nathalie Sami, Kyuwan Lee, Thomas A. Buchanan, Darcy Spicer, Debu Tripathy, Leslie Bernstein, Joanne Mortimer - Journal of Clinical Oncology 2018 cited by 354

  8. Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial

    Authors: Christina M. Dieli‐Conwright, Kerry S. Courneya, Wendy Demark‐Wahnefried, Nathalie Sami, Kyuwan Lee, Frank C. Sweeney, Christina F. Stewart, Thomas A. Buchanan, Darcy Spicer, Debu Tripathy, Leslie Bernstein, Joanne Mortimer - Breast Cancer Research 2018 cited by 320

  9. Pooled ctDNA analysis of MONALEESA phase III advanced breast cancer trials

    Authors: Fabrice André, Faye Su, Nadia Solovieff, Gabriel N. Hortobágyi, S. Chia, Patrick Neven, Aditya Bardia, Debu Tripathy, Y.-S. Lu, Agnes Lteif, T Taran, Naveen Babbar, DJ Slamon, Carlos L. Arteaga - Annals of Oncology 2023 cited by 90

  10. CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers

    Authors: Smruthi Vijayaraghavan, Cansu Karakaş, Iman Doostan, Xian Chen, Tuyen Bui, Min Yi, Akshara Singareeka Raghavendra, Yang Zhao, Sami I. Bashour, Nuhad K. Ibrahim, Meghan Karuturi, Jing Wang, Jeffrey D. Winkler, Ravi K. Amaravadi, Kelly K. Hunt, Debu Tripathy, Khandan Keyomarsi - Nature Communications 2017 cited by 293

  11. Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer

    Authors: Kurt W. Evans, Erkan Yuca, Stephen M. Scott, Ming Zhao, Natalia Paez Arango, Christian X. Cruz Pico, Turçin Saridogan, Maryam Shariati, Caleb A. Class, Christopher A. Bristow, Christopher P. Vellano, Xiaofeng Zheng, Ana M. González-Angulo, Xiaoping Su, Coya Tapia, Ken Chen, Argun Akçakanat, Bora Lim, Debu Tripathy, Timothy A. Yap, Maria Emilia Di Francesco, Giulio Draetta, Philip Jones, Timothy P. Heffernan, Joseph R. Marszalek, Funda Meric‐Bernstam - Cancer Research 2021 cited by 157

  12. Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer

    Authors: Charles L. Vogel, Melody Cobleigh, Debu Tripathy, John Gutheil, Lyndsay N. Harris, Louis Fehrenbacher, Dennis J. Slamon, Maureen Murphy, William Novotny, Michael Burchmore, Steven Shak, Stanford J. Stewart, Michael F. Press - Journal of Clinical Oncology 2002 cited by 1,859

  13. Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial

    Authors: Eve T. Rodler, Priyanka Sharma, William E. Barlow, Julie R. Gralow, Shannon L. Puhalla, Carey K. Anders, Lori J. Goldstein, Debu Tripathy, Ursa Brown‐Glaberman, Thu-Tam Huynh, Christopher S Szyarto, Andrew K. Godwin, Harsh B. Pathak, Elizabeth M. Swisher, Marc R. Radke, Kirsten M. Timms, Danika L. Lew, Jieling Miao, Lajos Pusztai, Daniel F. Hayes, Gabriel N. Hortobágyi - The Lancet Oncology 2023 cited by 98

  14. MRI-Based Digital Models Forecast Patient-Specific Treatment Responses to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

    Authors: Chengyue Wu, Angela M. Jarrett, Zijian Zhou, Nabil Elshafeey, Beatriz E. Adrada, Rosalind P. Candelaria, Rania M. Mohamed, Medine Böge, Lei Huo, Jason B. White, Debu Tripathy, Vicente Valero, Jennifer K. Litton, Clinton Yam, Jong Bum Son, Jingfei Ma, Gaiane M. Rauch, Thomas E. Yankeelov - Cancer Research 2022 cited by 73

  15. Prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer using deep learning on multiparametric MRI

    Authors: Zijian Zhou, Beatriz E. Adrada, Rosalind P. Candelaria, Nabil Elshafeey, Medine Böge, Rania M. Mohamed, Sanaz Pashapoor, Jia Sun, Zhan Xu, Bikash Panthi, Jong Bum Son, Mary S. Guirguis, Miral Patel, Gary J. Whitman, Tanya W. Moseley, Marion E. Scoggins, Jason B. White, Jennifer K. Litton, Vicente Valero, Kelly K. Hunt, Debu Tripathy, Wei Yang, Peng Wei, Clinton Yam, Mark D. Pagel, Gaiane M. Rauch, Jingfei Ma - Scientific Reports 2023 cited by 43

  16. Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers

    Authors: Juliana Navarro-Yepes, Nicole M. Kettner, Xiayu Rao, Cassandra Santaella Bishop, Tuyen Bui, Hannah F. Wingate, Akshara Singareeka Raghavendra, Yan Wang, Jing Wang, Ayşegül A. Şahin, Funda Meric‐Bernstam, Kelly K. Hunt, Senthil Damodaran, Debu Tripathy, Khandan Keyomarsi - Cancer Research 2023 cited by 52

  17. Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer

    Authors: Nicole M. Kettner, Smruthi Vijayaraghavan, Merih Güray Durak, Tuyen Bui, Mehrnoosh Kohansal, Min Jin Ha, Bin Liu, Xiayu Rao, Jing Wang, Min Yi, Jason P.W. Carey, Xian Chen, T. Kris Eckols, Akshara Singareeka Raghavendra, Nuhad K. Ibrahim, Meghan Karuturi, Stephanie S. Watowich, Ayşegül A. Şahin, David J. Tweardy, Kelly K. Hunt, Debu Tripathy, Khandan Keyomarsi - Clinical Cancer Research 2019 cited by 133

  18. Ribociclib (LEE011): Mechanism of Action and Clinical Impact of This Selective Cyclin-Dependent Kinase 4/6 Inhibitor in Various Solid Tumors

    Authors: Debu Tripathy, Aditya Bardia, William R. Sellers - Clinical Cancer Research 2017 cited by 242

  19. Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer

    Authors: Howard A. Burris, Arlene Chan, Aditya Bardia, J. Thaddeus Beck, Joohyuk Sohn, Patrick Neven, Debu Tripathy, Seock‐Ah Im, Stephen Chia, Francisco J. Esteva, Lowell L. Hart, Juan Pablo Zarate, Antonia Ridolfi, Karen Rodriguez Lorenc, Denise A. Yardley - British Journal of Cancer 2021 cited by 90

  20. EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer

    Authors: Xiaoping Wang, Takashi Semba, Ganiraju C. Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Phi, Troy Pearson, Steven Van Laere, Jared K. Burks, Evan N. Cohen, James M. Reuben, Fei Yang, Min Hu, Nicholas E. Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Vardhan Batra, Yichao Shen, Xiang H.-F. Zhang, Debu Tripathy, Naoto T. Ueno - Science Advances 2022 cited by 64

  21. Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease

    Authors: Melody Cobleigh, Charles L. Vogel, Debu Tripathy, Nicholas J. Robert, Suzy Scholl, Louis Fehrenbacher, Janet Wolter, Virginia Paton, Steven Shak, Gracie Lieberman, Dennis J. Slamon - Journal of Clinical Oncology 1999 cited by 2,790

  22. Central Nervous System Metastases in Patients with HER2-Positive Metastatic Breast Cancer: Incidence, Treatment, and Survival in Patients from registHER

    Authors: Adam Brufsky, Musa Mayer, Hope S. Rugo, Peter A. Kaufman, Elizabeth Tan-Chiu, Debu Tripathy, Iulia Cristina Tudor, Lisa I. Wang, Melissa Brammer, Mona Shing, Marianne Ulcickas Yood, Denise A. Yardley - Clinical Cancer Research 2011 cited by 400

  23. Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline Update

    Authors: Julienne E. Bower, Christina Lacchetti, Yesne Alici, Debra L. Barton, Deborah Watkins Bruner, Beverly Canin, Carmelita P. Escalante, Patricia A. Ganz, Sheila N. Garland, Shilpi Gupta, Heather Jim, Jennifer A. Ligibel, Kah Poh Loh, Luke J. Peppone, Debu Tripathy, Sriram Yennu, Suzanna M. Zick, Karen M. Mustian - Journal of Clinical Oncology 2024 cited by 217

  24. Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

    Authors: The I-SPY 1 TRIAL Investigators, Laura J. Esserman, Donald A. Berry, Maggie C.U. Cheang, Christina Yau, Charles M. Perou, Lisa A. Carey, Angela DeMichele, Joe W. Gray, Kathleen Conway‐Dorsey, Marc E. Lenburg, Meredith Buxton, Sarah Davis, Laura J. van’t Veer, Clifford A. Hudis, Koei Chin, Denise M. Wolf, Helen Krontiras, Leslie L. Montgomery, Debu Tripathy, Constance D. Lehman, Minetta C. Liu, Olufunmilayo I. Olopade, Hope S. Rugo, John T. Carpenter, Chad Livasy, Lynn G. Dressler, David C. Chhieng, Baljit Singh, Carolyn Mies, Joseph T. Rabban, Yunni-Yi Chen, Dilip D. Giri, Alfred Au, Nola M. Hylton - Breast Cancer Research and Treatment 2011 cited by 376